603
Views
0
CrossRef citations to date
0
Altmetric
MENOPAUSE

Black cohosh efficacy and safety for menopausal symptoms. The Spanish Menopause Society statement

ORCID Icon, , , , &
Pages 379-384 | Received 13 Feb 2022, Accepted 18 Mar 2022, Published online: 11 Apr 2022

References

  • Upton R. Black cohosh rhizome actaea racemosa L. syn. Cimicifuga racemosa (L) Nutt standards of analysis, quality control, and therapeutics. Santa Cruz: American Herbal Pharmacopoeia and Therapeutic Compendium; 2002. p. 1–38.
  • Henneicke-von Zepelin HH. 60 years of Cimicifuga racemosa medicinal products : Clinical research milestones, current study findings and current development. Wien Med Wochenschr. 2017;167(7-8):147–159.
  • Juliá MD, Ferrer J, Quereda F, et al. Posicionamiento de la asociación española Para el estudio de la menopausia sobre el uso clínico de la cimicífuga racemosa en el climaterio. Prog Obstet Ginecol. 2009;52(12):712–721.
  • Castelo-Branco C, Gambacciani M, Cano A, Minkin MJ, et al. Review & Meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence. Climacteric. 2021;24(2):109–119.
  • Beer AM, Neff A. Differentiated evaluation of extract-specific evidence on cimicifuga racemosa's efficacy and safety for climacteric complaints. Evid Based Complement Alternat Med. 2013;2013:1–21.
  • Beck V, Unterrieder E, Krenn L, et al. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol. 2003;84(2-3):259–268.
  • Reame NE, Lukacs JL, Padmanabhan V, et al. Black cohosh has Central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging. Menopause. 2008;15(5):832–840.
  • Nisslein T, Koetter U, Freudenstein J. In vitro binding of an iso-propanolic extract of black cohosh to selected Central nervous receptors. Maturitas. 2006; 54:S65.
  • Burdette JE, Liu J, Chen SN, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem. 2003;51(19):5661–5670.
  • Rhyu MR, Lu J, Webster DE, et al. Black cohosh (actaea racemosa, cimicifuga racemosa) behaves as a mixed competitive ligand and partial agonist at the human mu opiate receptor. J Agric Food Chem. 2006;54(26):9852–9857.
  • Hui Z, Xiaoyan M, Mukun Y, et al. Effects of black cohosh and estrogen on the hypothalamic nuclei of ovariectomized rats at different temperatures. J Ethnopharmacol. 2012;142(3):769–775.
  • Garcia de Arriba S, Henneicke-Von Zepelin HH, Dimpfel W, et al. Cimicifuga extract modulates brain activity: electropharmaco-gram from various brain areas in freely moving rats (Tele-Stereo- EEG). Maturitas. 2015;82(3):318.
  • Nappi RE, Malavasi B, Brundu B, et al. Efficacy of cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol. 2005;20(1):30–35.
  • Bai W, Henneicke-von Zepelin HH, Wang S, et al. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas. 2007;58(1):31–41.
  • Stoll W. Phytotherapeutikum beeinflußt atrophisches vaginalepithel: Doppelblindversuch cimicifuga vs. Oestrogenpraparat. Therapeutikon. 1987;1:23–31.
  • Osmers R, Friede M, Liske E, et al. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol. 2005;105(5 Pt 1):1074–1083.
  • Jiang K, Jin Y, Huang L, et al. Black cohosh improves objective sleep in postmenopausal women with sleep disturbance. Climacteric. 2015;18(4):559–567.
  • Uebelhack R, Blohmer JU, Graubaum HJ, et al. Black cohosh and St. John's wort for climacteric complaints: a randomized trial. Obstet Gynecol. 2006;107(2, Part 1):247–255. PMID: 16449108.
  • Liske E, Hänggi W, Henneicke-von Zepelin HH, et al. Physiological investigation of a unique extract of black cohosh (cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med. 2002;11(2):163–174.
  • Li Y, Cui M, Gao S. Efficacy of remifemin for control of climacteric symptoms. Prog Obstet Gynecol. 2011;20:462–465.
  • Henneicke-von Zepelin HH. High-dose isopropanolic cimicifuga racemosa-extract for climacteric complaints in perimenopausal women. Human reproduction; 12th World Congress Supplement. Venice. 2005.
  • Huang YX, Song L, Zhang X, et al. Clinical study of combined treatment of remifemin and paroxetine for perimenopausal depression. Zhonghua Yi Xue Za Zhi. 2013;93(8):600–602.
  • Sun N-X, Jin Z-J, Jia X-F, et al. Black cohosh improves vaginal atrophy in postmenopausal women. Acad J Second Military Med Univ. 2012;32(3):339–341.
  • Zhang Q, Zhuang Z, Chen T. 莉芙敏治疗围绝经期综合征的安全性和疗效研究 [the efficacy and safety of remifemin in the treatment of perimenopausae syndrome]. J Chengdu Med College. 2015;10(2):229–232.
  • Garcia-Perez MA, Pineda B, Hermenegildo C, et al. Isopropanolic cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line. Fertil Steril. 2009;91(4 Suppl):1347–1350.
  • Viereck V, Grundker C, Friess SC, et al. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts. J Bone Miner Res. 2005;20(11):2036–2043.
  • Stute P, Pickartz S. Zusatznutzen eines isopropanolischen cimicifuga-racemosa-Extrakts (iCR): positive beeinflussung von knochenstoffwechsel und -qualität. Z Phytother. 2015;36(01):18–22.
  • Cui G, Leng H, Wang K, et al. Effects of remifemin treatment on bone integrity and remodeling in rats with ovariectomy-induced osteoporosis. PLoS One. 2013;8(12):e82815.
  • Pockaj BA, Loprinzi CL, Sloan JA, et al. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest. 2004;22(4):515–521.
  • Rostock M, Fischer J, Mumm A, et al. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study . Gynecol Endocrinol. 2011;27(10):844–848.
  • Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol. 2001;19(10):2739–2745.
  • Wang C, Huang Q, Liang CL, et al. Effect of cimicifuga racemosa on menopausal syndrome caused by LHRH-a in breast cancer. J Ethnopharmacol. 2019;238:111840.
  • Henneicke-von Zepelin HH, Meden H, Kostev K, et al. Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. Int J Clin Pharmacol Ther. 2007;45(3):143–154.
  • Rebbeck TR, Troxel AB, Norman S, et al. A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. Int J Cancer. 2007;120(7):1523–1528.
  • Obi N, Chang-Claude J, Berger J, et al. The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a german case-control study. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2207–2213.
  • Bodinet C, Freudenstein J. Influence of cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells. Breast Cancer Res Treat. 2002;76(1):1–10.
  • Nisslein T, Freudenstein J, editors. Synergistic effects of black cohosh and tamoxifen in an animal model of mammary carcinoma. 6th European congress on menopause; 2003; Maturitas.
  • Li B, Takeda H, Tsuiji K, et al. The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway. Gynecol Endocrinol. 2013;29(1):87–90.
  • Tadakawa M, Takeda T, Li B, et al. The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1/hypoxia-inducible factor-1α signaling pathway in ELT-3 cells. Mol Cell Endocrinol. 2015;399:1–8.
  • Ciarmela P, Islam MS, Reis FM, et al. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update. 2011;17(6):772–790.
  • Li W, Sun N-X, Chen X, et al. 早期子宫内膜癌患者术后应用黑升麻制剂治疗绝经相关症状 [cimicifuga racemosa for treatment of menopausal symptoms in patients with early endometrial cancer after operation]. Acad J Second Mil Med Univ. 2013;32(5):562–564.
  • Liske E. Phytokombination lindert psychovegetative leiden. TW Gynäkologie. 1997;10:172–175. [Phytocombination alleviates psychovegatative disorders].
  • Chen J, Gao H, Li Q, et al. Efficacy and safety of remifemin on peri-menopausal symptoms induced by post-operative GnRH-a therapy for endometriosis: a randomized study versus tibolone. Med Sci Monit. 2014;20:1950–1957.
  • Naser B, Schnitker J, Minkin MJ, et al. Suspected black cohosh hepatotoxicity: no evidence by Meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. Menopause. 2011;18(4):366–375.
  • Teschke R. Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review. Menopause. 2010;17(2):426–440.
  • Hirschberg AL, Edlund M, Svane G, et al. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Menopause. 2007;14(1):89–96.
  • Stute P, Nisslein T, Götte M, et al. Effects of black cohosh on estrogen biosynthesis in normal breast tissue in vitro. Maturitas. 2007;57(4):382–391.
  • Rice S, Amon A, Whitehead SA. Ethanolic extracts of black cohosh (actaea racemosa) inhibit growth and oestradiol synthesis from oestrone sulphate in breast cancer cells. Maturitas. 2007;56(4):359–367.
  • Einbond LS, Wen-Cai Y, He K, et al. Growth inhibitory activity of extracts and compounds from cimicifuga species on human breast cancer cells. Phytomedicine. 2008;15(6-7):504–511.
  • Hostanska K, Nisslein T, Freudenstein J, et al. Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res Treat. 2004;84(2):151–160.
  • Lundström E, Hirschberg AL, Söderqvist G. Digitized assessment of mammographic breast density–effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo. Maturitas. 2011;70(4):361–364.
  • Ruhlen RL, Haubner J, Tracy JK, et al. Black cohosh does not exert an estrogenic effect on the breast. Nutr Cancer. 2007;59(2):269–277.
  • Rockwell S, Liu Y, Higgins SA. Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res Treat. 2005;90(3):233–239.
  • Nisslein T, Freudenstein J. Coadministration of the aromatase inhibitor formestane and an isopropanolic extract of black cohosh in a rat model of chemically induced mammary carcinoma. Planta Med. 2007;73(4):318–322.
  • Naser B, Castelo-Branco C, Meden H, et al. Weight gain in menopause: systematic review of adverse events in women treated with black cohosh. Climacteric. 2021;1–8.
  • Menopause: diagnosis and management. NICE guideline (NG23); [cited 2021 September 15]. Available from: https://www.nice.org.uk/guidance/ng23., 2019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.